206 related articles for article (PubMed ID: 16266700)
21. Neurobiology and treatment in alcoholism--recent findings regarding Lesch's typology of alcohol dependence.
Hillemacher T; Bleich S
Alcohol Alcohol; 2008; 43(3):341-6. PubMed ID: 18339813
[TBL] [Abstract][Full Text] [Related]
22. Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe.
Bramness JG; Mann K; Wurst FM
Eur Addict Res; 2016; 22(6):318-321. PubMed ID: 27438908
[TBL] [Abstract][Full Text] [Related]
23. Baclofen: a new drug for the treatment of alcohol dependence.
Addolorato G; Leggio L; Agabio R; Colombo G; Gasbarrini G
Int J Clin Pract; 2006 Aug; 60(8):1003-8. PubMed ID: 16893442
[TBL] [Abstract][Full Text] [Related]
24. Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies.
Rolland B; Paille F; Gillet C; Rigaud A; Moirand R; Dano C; Dematteis M; Mann K; Aubin HJ
CNS Neurosci Ther; 2016 Jan; 22(1):25-37. PubMed ID: 26768685
[TBL] [Abstract][Full Text] [Related]
25. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
[TBL] [Abstract][Full Text] [Related]
26. Acceptance of pharmacotherapy for relapse prevention by chronic alcoholics.
Wetterling T; Veltrup C; Junghanns K; Krömer-Olbrisch T; Schneider U
Pharmacopsychiatry; 2001 Jul; 34(4):142-6. PubMed ID: 11518475
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic management of relapse prevention in addictive disorders.
Sofuoglu M; Kosten TR
Psychiatr Clin North Am; 2004 Dec; 27(4):627-48. PubMed ID: 15550284
[TBL] [Abstract][Full Text] [Related]
28. Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence.
Miller NS; Gold MS
Am Fam Physician; 1998 Jul; 58(1):139-46. PubMed ID: 9672434
[TBL] [Abstract][Full Text] [Related]
29. Current progress in pharmacologic treatment strategies for alcohol dependence.
Clapp P
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):427-35. PubMed ID: 22943122
[TBL] [Abstract][Full Text] [Related]
30. Assessing the efficacy of medical treatments for alcohol use disorders.
Moak DH
Expert Opin Pharmacother; 2004 Oct; 5(10):2075-89. PubMed ID: 15461543
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological treatments in alcohol use disorders: state of art and new perspectives.
Guglielmo R; Ioime L; Solaroli S; Janiri L
Clin Ter; 2015; 166(6):262-70. PubMed ID: 26794815
[TBL] [Abstract][Full Text] [Related]
32. Novel pharmacotherapeutic targets for the management of drug addiction.
Heidbreder C
Eur J Pharmacol; 2005 Dec; 526(1-3):101-12. PubMed ID: 16253234
[TBL] [Abstract][Full Text] [Related]
33. The application of machine learning techniques as an adjunct to clinical decision making in alcohol dependence treatment.
Connor JP; Symons M; Feeney GF; Young RM; Wiles J
Subst Use Misuse; 2007; 42(14):2193-206. PubMed ID: 18098000
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetic treatments for drug addiction: alcohol and opiates.
Haile CN; Kosten TA; Kosten TR
Am J Drug Alcohol Abuse; 2008; 34(4):355-81. PubMed ID: 18584566
[TBL] [Abstract][Full Text] [Related]
35. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.
Harris AH; Oliva E; Bowe T; Humphreys KN; Kivlahan DR; Trafton JA
Psychiatr Serv; 2012 Jul; 63(7):679-85. PubMed ID: 22549276
[TBL] [Abstract][Full Text] [Related]
36. Compliance with aftercare treatment, including disulfiram, and effect on outcome in alcohol-dependent patients.
Neto D; Lambaz R; Tavares JE
Alcohol Alcohol; 2007; 42(6):604-9. PubMed ID: 17878216
[TBL] [Abstract][Full Text] [Related]
37. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants.
Ait-Daoud N; Malcolm RJ; Johnson BA
Addict Behav; 2006 Sep; 31(9):1628-49. PubMed ID: 16472931
[TBL] [Abstract][Full Text] [Related]
38. [The role of the glutamatergic system in alcohol addiction].
Spanagel R
Fortschr Neurol Psychiatr; 2003 Jul; 71 Suppl 1():S33-5. PubMed ID: 12947541
[TBL] [Abstract][Full Text] [Related]
39. An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence.
Johnson BA
Expert Opin Pharmacother; 2004 Sep; 5(9):1943-55. PubMed ID: 15330732
[TBL] [Abstract][Full Text] [Related]
40. Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?
Kleczkowska P; Smaga I; Filip M; Bujalska-Zadrozny M
Neurotox Res; 2016 Nov; 30(4):698-714. PubMed ID: 27484692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
